Diseases, Conditions, Syndromes

New animal model shows effective treatment for latent tuberculosis

A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed ...

Diseases, Conditions, Syndromes

How an AI solution can design new tuberculosis drug regimens

With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs—including unlikely candidates—can be combined in new ways to create more effective ...

Diseases, Conditions, Syndromes

Boosting host immune defenses to treat tuberculosis

Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard for people to sustain. Moreover, the bacteria often develop drug resistance, and many people ...

Immunology

Immune system targets vitamin B12 pathway to neutralize bacteria

Close to 1.8 billion people worldwide are infected with Mycobacterium tuberculosis (Mtb), the common and occasionally deadly bacterium that causes millions of cases of tuberculosis each year. The bacteria, having coevolved ...

Diseases, Conditions, Syndromes

Researchers move closer to new vaccine for killer TB

Scientists said Tuesday they are closing in on a new game-changing vaccine for tuberculosis, the world's deadliest infectious disease that claimed some 1.5 million lives last year.

page 16 from 40